20664535|t|The effect of donepezil treatment on cardiovascular mortality.
20664535|a|The acetylcholinesterase inhibitor donepezil hydrochloride improves cognitive function in patients with Alzheimer's disease and vascular dementia. Given acetylcholine's important actions on the heart, we undertook a retrospective cohort investigation to assess whether donepezil usage affects cardiovascular mortality. In patients treated with donepezil, hazard ratios for total and cardiovascular mortality were 0.68 (P = 0.045, 95% confidence interval 0.46-0.99) and 0.54 (P = 0.042, 95% confidence interval 0.30-0.98), respectively. The apparent survival benefit in donepezil-treated patients should not be overinterpreted. Prospective clinical trials are warranted.
20664535	14	23	donepezil	Chemical	MESH:D000077265
20664535	67	87	acetylcholinesterase	Gene	43
20664535	98	121	donepezil hydrochloride	Chemical	MESH:D000077265
20664535	153	161	patients	Species	9606
20664535	167	186	Alzheimer's disease	Disease	MESH:D000544
20664535	191	208	vascular dementia	Disease	MESH:D015140
20664535	216	229	acetylcholine	Chemical	MESH:D000109
20664535	332	341	donepezil	Chemical	MESH:D000077265
20664535	385	393	patients	Species	9606
20664535	407	416	donepezil	Chemical	MESH:D000077265
20664535	632	641	donepezil	Chemical	MESH:D000077265
20664535	650	658	patients	Species	9606
20664535	Negative_Correlation	MESH:D000077265	MESH:D015140
20664535	Negative_Correlation	MESH:D000077265	MESH:D000544
20664535	Negative_Correlation	MESH:D000077265	43

